Search

Financial results - CLINICAL RESEARCH & INNOVATION S.R.L.

0.00
Financial Summary - Clinical Research & Innovation S.r.l.
Unique identification code: 39634429
Registration number: J26/1112/2018
Nace: 7219
Sales - Ron
310.604
Net Profit - Ron
30.830
Employees
8
Open Account
Company Clinical Research & Innovation S.r.l. with Fiscal Code 39634429 recorded a turnover of 2024 of 310.604, with a net profit of 30.830 and having an average number of employees of 8. The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Clinical Research & Innovation S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 6.662 163.232 177.913 108.865 184.528 157.651 310.604
Total Income - EUR - - - 6.662 163.232 186.124 115.747 258.860 277.612 339.399
Total Expenses - EUR - - - 404 64.791 125.561 94.962 229.914 245.451 299.251
Gross Profit/Loss - EUR - - - 6.258 98.441 60.563 20.785 28.946 32.161 40.148
Net Profit/Loss - EUR - - - 6.058 96.653 58.784 19.696 27.101 30.450 30.830
Employees - - - 0 1 6 6 8 9 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 98.1%, from 157.651 euro in the year 2023, to 310.604 euro in 2024. The Net Profit increased by 550 euro, from 30.450 euro in 2023, to 30.830 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Clinical Research & Innovation S.r.l.

Rating financiar

Financial Rating -
CLINICAL RESEARCH & INNOVATION...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Clinical Research & Innovation...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Clinical Research & Innovation...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Clinical Research & Innovation...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Clinical Research & Innovation S.r.l. - CUI 39634429

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 2.430 305.060 292.059 310.921 441.100 513.486 427.517
Current Assets - - - 4.429 79.445 59.913 74.472 128.334 158.897 189.832
Inventories - - - 2.195 0 22.423 41.535 72.530 83.821 6.951
Receivables - - - 215 76.889 1.062 26.742 53.932 73.510 182.497
Cash - - - 2.019 2.556 36.428 6.195 1.872 1.565 384
Shareholders Funds - - - 6.101 96.703 86.258 104.042 131.465 161.517 191.444
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 757 287.802 239.255 262.361 386.819 445.340 389.540
Income in Advance - - - 0 0 26.459 18.990 51.150 65.526 36.365
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7220
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 189.832 euro in 2024 which includes Inventories of 6.951 euro, Receivables of 182.497 euro and cash availability of 384 euro.
The company's Equity was valued at 191.444 euro, while total Liabilities amounted to 389.540 euro. Equity increased by 30.830 euro, from 161.517 euro in 2023, to 191.444 in 2024. The Debt Ratio was 63.1% in the year 2024.
Monitors the Company

Risk Reports Prices

Reviews - Clinical Research & Innovation S.r.l.

Comments - Clinical Research & Innovation S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.